digiMedical Solutions, Inc. Announces Partnership With HESS Corporation to Expand Customer Base

COLLEYVILLE, TX, Feb 14 (MARKET WIRE) --
digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced a
partnership with HESS Corporation (www.hess.com). Through the partnership,
patients
bringing new prescriptions to the Harrington Pharmacy chain in the Naples and
Fort Myers, Florida, markets will receive $10 HESS fuel gift cards. HESS
Corporation, a leader in the exploration, production and sale of natural gas
and crude oil, operates HESS Gasoline Stations nationwide. This partnership will
supplementdigiMedical's campaign to grow the local markets in which the Company
operates
while also aggressively marketing the Company's digital prescription system,
digiRX(TM). digiMedical expects new doctors and patients to be added to the
digiRX(TM) system within the next few weeks.

digiMedical Solutions, a Microsoft Partner based in the Dallas-Ft. Worth
metroplex, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy, securely
and
in compliance with all DEA and HIPAA requirements. The suite of software
includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting. Additionally, the company owns and operates five
pharmaciesthroughout Texas and Florida.

To be added to digiMedical's corporate e-mail list for shareholders and
interested investors, please send an e-mail to ir@digimedical.com.

About HESS Corporation (TM) (www.hess.com)

Hess Corporation is a leading global independent energy company, engaged
inthe exploration and production of crude oil and natural gas, as well as in
refining and in marketing refined petroleum products, natural gas, and
electricity. Our vision is to maximize shareholder value by enhancing financial
performance and providing long-term profitable growth. We are committed to
meeting the highest standards of corporate citizenship by protecting the
health and safety of our employees, safeguarding the environment and creating
a long-lasting, positive impact on the communities in which we do business.

About digiMedical Solutions, Inc. (TM) (www.digiMedical.com)

digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology company
focused
on developing next generation, digital medical technology with an emphasis on
digital prescriptions (d-Prescriptions) that closely align the doctor,
pharmacist
and patient. The company's planned growth will come from three channels:
direct marketing of the company's wireless based d-prescription technology to
physicians, acquisition of independent pharmacy chains and the sale of select
territories to "market partners'' licensed to exploit the digiMedical
Solutions(TM)
model. digiMedical Solutions, Inc.(TM) currently owns and operates five
pharmacies
throughoutTexas and Florida and is a Microsoft Independent Software Vendor
(ISV).
digiMedical Solutions(TM) unique business model connects physicians, patients
and
pharmacies with next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for
purposes of safe harbor provided by Section 21E of the Securities Exchange
Act of 1934, as amended. Forward-Looking Statements may be identified by
words including "anticipate," "await," "envision," "foresee," "aim at,"
"believe,"
"intends," "estimates" including without limitation, those relating to the
company's future business prospects, are subject to certain risks and
uncertainties that could cause actual results to differ materially from those
indicated in the Forward-Looking Statements. Readers are directed to the
company's
filings with the U.S. Securities and Exchange Commission for additional
information and a presentation of the risks and uncertainties that may
affect the company's business and results of operations.

Contact:
digiMedical Solutions, Inc.
Investor Relations
(214) 722-3029
ir@digimedical.com

Copyright 2008, Market Wire, All rights reserved.

-0-